NTRA Natera, Inc. - Common Stock
$316,51
Prix · Aoû 18, 2026
Données fondamentales au Aoû 7, 2026
Fourchette 52 semaines
$157–$326
94% of range
Note des analystes
BUY
30 analysts
Objectif de cours
$331
+4% upside
P/E (TTM)
-208.2
ROE
-14.1%
Marge nette
-9.0%
À propos de Natera, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
Lire la suite
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
NTRA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$316.51
Capitalisation Boursière
$44.21B
P/E (TTM)
-208.2
BPA (TTM)
$-1.52
Revenus (TTM)
$2.31B
Rendement div.
—
ROE
-14.1%
Dette/Capitaux propres
0.0
Fourchette 52 semaines
$157 – $326
NTRA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$2.31B
2016-12-31
→
2025-12-31
BPA
$-1.52
2016-12-31
→
2025-12-31
Flux de trésorerie libre
$109M
2016-12-31
→
2025-12-31
Marges
-9.0%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
NTRA
Médiane des pairs
P/E (TTM)
-208.2
17.7
P/S (TTM)
19.2
6.8
P/B
25.8
6.4
Price / FCF (Cours / FCF)
405.2
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
NTRA
Médiane des pairs
Operating Margin (Marge d'exploitation)
-13.4%
—
Net Profit Margin (Marge nette)
-9.0%
20.3%
ROA
-10.3%
11.4%
ROE
-14.1%
16.8%
ROIC
-13.4%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
NTRA
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.0
—
Current Ratio (Ratio de liquidité)
3.4
3.4
Quick Ratio (Ratio de liquidité réduite)
0.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
NTRA
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
35.9%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
41.1%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
42.6%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
NTRA
Médiane des pairs
NTRA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
30 analystes
- Achat fort 12 40,0%
- Achat 14 46,7%
- Conserver 4 13,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
21 analystes · 2026-08-17
Médiane
$348.00
Moyenne
$330.64
Maintenant
$316.51
Bas
$193.00
Haut
$375.00
Objectif médian
$348.00
+9,9%
Objectif moyen
$330.64
+4,5%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.11%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.47 | $-0.50 | 0.03% |
| 31 mars 2026 | $-0.60 | $-0.55 | -0.05% |
| 31 décembre 2025 | $0.36 | $-0.52 | 0.88% |
| 30 septembre 2025 | $-0.64 | $-0.38 | -0.26% |
| 30 juin 2025 | $-0.74 | $-0.63 | -0.11% |
| 31 mars 2025 | $-0.50 | $-0.65 | 0.15% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| AMGN | $176.35B | 23.0 | 10.0% | 21.0% | 95.9% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
Bilan 28
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
Flux de trésorerie 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | -271,604,000 | 137,187,000 | 136,388,000 | 134,750,000 | -242,724,000 | 123,775,000 | 122,853,000 | 120,814,000 | -225,631,000 | 115,171,000 | 113,690,000 | 111,767,000 | -190,801,000 | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | -271,604,000 | 137,187,000 | 136,388,000 | 134,750,000 | -242,724,000 | 123,775,000 | 122,853,000 | 120,814,000 | -225,631,000 | 115,171,000 | 113,690,000 | 111,767,000 | -190,801,000 | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
Flux de trésorerie 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
Valorisation (TTM) 13
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.59B | $2.34B | · | $2.08B | $1.90B | $1.72B | · | $1.49B | $1.31B | $1.14B | · | $982M | $912M | $845M | · | $761M | |
| Net Income TTM | $-341M | $-341M | · | $-287M | $-237M | $-204M | · | $-246M | $-325M | $-424M | · | $-478M | $-514M | $-542M | · | $-556M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -110.8 | -80.6 | · | -75.2 | -93.9 | -87.3 | · | -61.3 | -39.0 | -24.7 | · | -10.1 | -9.8 | -10.2 | · | -7.5 | |
| P/S | 15.1 | 12.2 | · | 10.6 | 12.2 | 11.2 | · | 10.6 | 10.2 | 9.8 | · | 5.4 | 6.1 | 7.5 | · | 5.6 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| P / FCF | · | 1582.9 | · | · | · | 849.1 | · | · | · | 1672.1 | · | · | · | -68.0 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -31.9 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 5.0 | |
| Earnings Yield | -0.90% | -1.2% | · | -1.3% | -1.1% | -1.1% | · | -1.6% | -2.6% | -4.1% | · | -9.9% | -10.2% | -9.8% | · | -13.3% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $2.31B | $1.70B | $1.08B | $820M | $625M |
| Marge d'exploitation % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| Résultat net | $-208M | $-190M | $-435M | $-548M | $-472M |
| BPA dilué | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Ratio de liquidité | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| Ratio de liquidité réduite | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $109M | $69M | $-286M | $-479M | $-376M |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Natera Inc. (NTRA) : Choix d'action du milliardaire Tom Steyer avec un grand potentiel de hausse
- Stanley Druckenmiller a réalisé un pari majeur qui semble toujours attrayant aujourd'hui et a réduit 2 positions de premier plan
- Natera Inc. (NTRA) : Le potentiel de hausse attire le milliardaire Stan Druckenmiller
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 935 déclarants · $20.5B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 172 (+66 vs T. préc.) | 63 (-37 vs T. préc.) | 340 (+35 vs T. préc.) | 248 (-6 vs T. préc.) | +27.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1 690 649 234 | 6 228 216 | 8,25% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 569 697 628 | 5 782 640 | 7,66% | Actions |
| FMR LLC | $1 189 034 607 | 4 380 308 | 5,80% | Actions |
| STATE STREET CORP | $992 317 506 | 3 655 618 | 4,84% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $965 965 683 | 3 558 540 | 4,71% | Actions |
| Castle Hook Partners LP | $704 759 120 | 2 596 276 | 3,44% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $644 934 457 | 2 382 981 | 3,15% | Actions |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602 175 451 | 2 218 366 | 2,94% | Actions |
| NORGES BANK | $496 243 717 | 1 828 122 | 2,42% | Actions |
| FRED ALGER MANAGEMENT, LLC | $467 285 974 | 1 721 444 | 2,28% | Actions |
| Sofinnova Investments, Inc. | $420 823 506 | 1 550 280 | 2,05% | Actions |
| Capital World Investors | $408 365 851 | 1 504 387 | 1,99% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408 180 994 | 1 503 706 | 1,99% | Actions |
| MAVERICK CAPITAL LTD | $368 266 171 | 1 356 663 | 1,80% | Actions |
| D. E. Shaw & Co., Inc. | $322 096 327 | 1 186 577 | 1,57% | Actions |
| GOLDMAN SACHS GROUP INC | $311 099 616 | 1 146 066 | 1,52% | Actions |
| Clearbridge Investments, LLC | $276 424 438 | 1 018 325 | 1,35% | Actions |
| RTW INVESTMENTS, LP | $271 450 000 | 1 000 000 | 1,32% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $249 356 413 | 918 609 | 1,22% | Actions |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197 243 187 | 726 628 | 0,96% | Actions |
| ARK Investment Management LLC | $186 989 592 | 688 855 | 0,91% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $174 716 892 | 643 643 | 0,85% | Actions |
| Chevy Chase Trust Holdings, LLC | $162 830 912 | 599 856 | 0,79% | Actions |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160 551 817 | 591 460 | 0,78% | Actions |
| FIRST TRUST ADVISORS LP | $138 768 953 | 511 214 | 0,68% | Actions |
| GILDER GAGNON HOWE & CO LLC | $135 199 396 | 498 064 | 0,66% | Actions |
| AMERICAN CENTURY COMPANIES INC | $129 951 802 | 478 732 | 0,63% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $125 949 543 | 463 988 | 0,61% | Actions |
| Avala Global LP | $124 867 000 | 460 000 | 0,61% | Actions |
| JANE STREET GROUP, LLC | $120 781 406 | 444 949 | 0,59% | Actions |
| Robeco Institutional Asset Management B.V. | $110 918 814 | 408 616 | 0,54% | Actions |
| VIKING GLOBAL INVESTORS LP | $106 053 886 | 390 694 | 0,52% | Actions |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $105 594 050 | 389 000 | 0,52% | Actions |
| Driehaus Capital Management LLC | $104 202 054 | 383 872 | 0,51% | Actions |
| GOLDMAN SACHS GROUP INC | $103 829 625 | 382 500 | 0,51% | Option d'achat |
| Swiss National Bank | $103 096 710 | 379 800 | 0,50% | Actions |
| JANE STREET GROUP, LLC | $100 300 775 | 369 500 | 0,49% | Option de vente |
| Amova Asset Management Americas, Inc. | $99 926 238 | 368 066 | 0,49% | Actions |
| Man Group plc | $97 455 436 | 359 018 | 0,48% | Actions |
| California Public Employees Retirement System | $93 399 430 | 344 076 | 0,46% | Actions |
| Squarepoint Ops LLC | $91 279 949 | 336 268 | 0,45% | Actions |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $84 486 098 | 311 240 | 0,41% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82 819 395 | 305 100 | 0,40% | Option de vente |
| DIMENSIONAL FUND ADVISORS LP | $82 812 880 | 305 076 | 0,40% | Actions |
| COATUE MANAGEMENT LLC | $80 563 646 | 296 790 | 0,39% | Actions |
| Capital Impact Advisors, LLC | $80 411 091 | 296 228 | 0,39% | Actions |
| AMERIPRISE FINANCIAL INC | $75 314 616 | 277 451 | 0,37% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $74 936 546 | 276 064 | 0,37% | Actions |
| CITADEL ADVISORS LLC | $72 099 020 | 265 607 | 0,35% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $71 251 553 | 262 485 | 0,35% | Actions |
| ORBIMED ADVISORS LLC | $71 119 900 | 262 000 | 0,35% | Actions |
| TWO SIGMA ADVISERS, LP | $70 490 993 | 307 700 | 0,34% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $70 377 484 | 259 265 | 0,34% | Actions |
| PointState Capital LP | $70 037 357 | 258 012 | 0,34% | Actions |
| Point72 Asset Management, L.P. | $68 655 134 | 252 920 | 0,34% | Actions |
| Assenagon Asset Management S.A. | $68 098 390 | 250 869 | 0,33% | Actions |
| BlackRock, Inc. | $61 219 847 | 225 529 | 0,30% | Actions |
| National Pension Service | $61 139 769 | 225 234 | 0,30% | Actions |
| ALLIANCEBERNSTEIN L.P. | $58 410 679 | 292 068 | 0,29% | Actions |
| TD Asset Management Inc | $56 207 523 | 207 064 | 0,27% | Actions |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | $55 932 001 | 206 049 | 0,27% | Actions |
| CITADEL ADVISORS LLC | $54 561 450 | 201 000 | 0,27% | Option de vente |
| Artemis Investment Management LLP | $54 313 616 | 200 087 | 0,27% | Actions |
| NEUBERGER BERMAN GROUP LLC | $52 978 986 | 195 170 | 0,26% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $50 424 281 | 185 759 | 0,25% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $49 380 284 | 181 913 | 0,24% | Actions |
| Eversept Partners, LP | $47 722 810 | 175 807 | 0,23% | Actions |
| Erste Asset Management GmbH | $47 112 625 | 173 011 | 0,23% | Actions |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $47 109 261 | 173 547 | 0,23% | Actions |
| RHUMBLINE ADVISERS | $46 531 361 | 171 418 | 0,23% | Actions |
| JENNISON ASSOCIATES LLC | $46 107 586 | 169 857 | 0,23% | Actions |
| TUDOR INVESTMENT CORP ET AL | $45 830 804 | 168 837 | 0,22% | Actions |
| LPL Financial LLC | $45 315 137 | 166 937 | 0,22% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44 300 640 | 163 200 | 0,22% | Option d'achat |
| Qube Research & Technologies Ltd | $43 724 895 | 161 079 | 0,21% | Actions |
| IEQ CAPITAL, LLC | $40 419 133 | 148 901 | 0,20% | Actions |
| Ensign Peak Advisors, Inc | $39 971 827 | 147 253 | 0,20% | Actions |
| JANE STREET GROUP, LLC | $39 930 295 | 147 100 | 0,19% | Option d'achat |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $39 561 022 | 197 815 | 0,19% | Actions |
| MILLENNIUM MANAGEMENT LLC | $39 068 984 | 143 927 | 0,19% | Actions |
| ROYAL BANK OF CANADA | $38 963 000 | 143 535 | 0,19% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $38 891 999 | 143 275 | 0,19% | Actions |
| HighTower Advisors, LLC | $38 255 720 | 140 931 | 0,19% | Actions |
| Caption Management, LLC | $38 003 000 | 140 000 | 0,19% | Option d'achat |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $37 658 258 | 138 730 | 0,18% | Actions |
| Rokos Capital Management LLP | $37 210 859 | 137 049 | 0,18% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $36 308 609 | 133 758 | 0,18% | Actions |
| RAYMOND JAMES FINANCIAL INC | $35 775 481 | 131 794 | 0,17% | Actions |
| MAPLELANE CAPITAL, LLC | $34 338 425 | 126 500 | 0,17% | Option d'achat |
| CANADA PENSION PLAN INVESTMENT BOARD | $33 741 235 | 124 300 | 0,16% | Actions |
| BANK OF AMERICA CORP /DE/ | $32 343 539 | 119 151 | 0,16% | Actions |
| Davern Capital Partners, LP | $32 295 764 | 118 975 | 0,16% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $32 267 262 | 118 870 | 0,16% | Actions |
| ThornTree Capital Partners LP | $31 493 900 | 116 021 | 0,15% | Actions |
| CITADEL ADVISORS LLC | $30 918 155 | 113 900 | 0,15% | Option d'achat |
| MARSHALL WACE, LLP | $30 550 069 | 112 544 | 0,15% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $30 538 398 | 112 501 | 0,15% | Actions |
| UBS Group AG | $29 990 339 | 110 482 | 0,15% | Actions |
| Science & Technology Partners, L.P. | $29 826 926 | 109 880 | 0,15% | Actions |
| AVIVA PLC | $29 381 205 | 108 238 | 0,14% | Actions |
Initiés de la société 21 initiés · 1 dirigeants · 12 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert Alan Schueren | Chief Operating Officer | 7 octobre 2020 M | 52 855 | 0 | 0 | $0 |
| Rowan E Chapman | Administrateur | 15 juillet 2026 S | 4 663 | 0 | 2 | $-679 637 |
| Eric H Rubin | Administrateur | 26 juin 2026 A | 2 204 | 0 | 0 | $0 |
| Monica Bertagnolli | Administrateur | 26 juin 2026 A | 7 020 | 0 | 0 | $0 |
| Gail Boxer Marcus | Administrateur | 26 juin 2026 A | 7 852 | 0 | 1 | $-651 646 |
| Roy D. Baynes | Administrateur | 26 juin 2026 A | 20 158 | 0 | 0 | $0 |
| Thomas J. Lynch Jr. | Administrateur | 26 juin 2026 A | 1 905 | 0 | 0 | $0 |
| Herm Rosenman | Administrateur | 26 juin 2026 A | 5 927 | 0 | 5 | $-15 143 996 |
| ROELOF BOTHA ("RB") | Administrateur | 26 juin 2026 A | 4 585 | 0 | 6 | $-17 184 060 |
| Dr. James I. Healy | Administrateur | 13 décembre 2023 S | 0 | 0 | 0 | $0 |
| Todd C Cozzens | Administrateur | 12 juin 2020 A | 7 278 | 0 | 0 | $0 |
| John Steuart | Administrateur | 16 mai 2019 M | 7 278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | Administrateur | 16 mai 2019 M | 52 009 | 0 | 0 | $0 |
| Jonathan Sheena | — | 10 août 2026 S | 230 464 | 0 | 41 | $-7 235 616 |
| Matthew Rabinowitz | — | 7 août 2026 S | 2 000 | 0 | 25 | $-23 012 521 |
| Michael Burkes Brophy | — | 4 août 2026 S | 51 637 | 0 | 7 | $-1 498 665 |
| John Fesko | — | 3 août 2026 S | 183 774 | 0 | 3 | $-519 299 |
| Solomon Moshkevich | — | 3 août 2026 S | 129 019 | 0 | 13 | $-2 685 306 |
| Daniel Rabinowitz | — | 3 août 2026 S | 170 073 | 0 | 19 | $-13 604 463 |
| Steven Leonard Chapman | — | 3 août 2026 S | 99 897 | 0 | 10 | $-2 476 206 |
| Ruth Williams Brinkley | — | 24 avril 2026 A | 5 475 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 dépôts | 13 février 2020 | — | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 103 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| GNOM · Global X Funds | 4,15% | 10 370 NS | 31 mai 2026 | N-PORT |
| ARKG · ARK ETF Trust | 4,07% | 243 718 NS | 30 avril 2026 | N-PORT |
| IBB · iShares Trust | 2,79% | 1 002 768 SH | 8 août 2026 | Quotidien |
| MEDI · Harbor ETF Trust | 2,35% | 3 142 NS | 30 avril 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 2,22% | 81 682 SH | 8 août 2026 | Quotidien |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,17% | 5 611 NS | 30 avril 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,72% | 7 656 NS | 31 mai 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,57% | 13 843 NS | 30 avril 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,43% | 2 615 NS | 31 mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,34% | 56 770 NS | 30 avril 2026 | N-PORT |
| ARKK · ARK ETF Trust | 1,17% | 369 404 NS | 30 avril 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 2 954 NS | 30 avril 2026 | N-PORT |
| IWP · iShares Trust | 1,04% | 789 272 SH | 8 août 2026 | Quotidien |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1 802 288 SH | 8 août 2026 | Quotidien |
| LABU · Direxion Shares ETF Trust | 0,98% | 24 696 NS | 30 avril 2026 | N-PORT |
| TAX · EA Series Trust | 0,92% | 1 046 NS | 29 mai 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0,68% | 1 580 NS | 30 avril 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0,66% | 1 989 NS | 31 mai 2026 | N-PORT |
| TEXN · iShares Trust | 0,63% | 396 SH | 8 août 2026 | Quotidien |
| SMLF · iShares Trust | 0,60% | 95 727 SH | 8 août 2026 | Quotidien |
| IYH · iShares Trust | 0,59% | 81 823 SH | 8 août 2026 | Quotidien |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,56% | 54 813 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,54% | 404 713 SH | 8 août 2026 | Quotidien |
| CANC · Tema ETF Trust | 0,54% | 4 238 NS | 31 mai 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,48% | 60 571 NS | 31 mai 2026 | N-PORT |
| IMCG · iShares Trust | 0,48% | 74 206 SH | 8 août 2026 | Quotidien |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 29 486 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1 643 356 SH | 8 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3 120 454 SH | 8 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,44% | 60 581 NS | 30 avril 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,40% | 41 NS | 30 avril 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,28% | 8 068 NS | 30 avril 2026 | N-PORT |
| IWR · iShares Trust | 0,26% | 555 978 SH | 8 août 2026 | Quotidien |
| GSLC · Goldman Sachs ETF Trust | 0,26% | 178 926 NS | 31 mai 2026 | N-PORT |
| SIZE · iShares Trust | 0,25% | 4 071 SH | 8 août 2026 | Quotidien |
| IMCB · iShares Trust | 0,25% | 15 707 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,24% | 21 798 SH | 8 août 2026 | Quotidien |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,24% | 1 020 NS | 31 mai 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,24% | 17 374 SH | 8 août 2026 | Quotidien |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,24% | 5 580 NS | 30 avril 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,24% | 558 NS | 31 mai 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 23 988 NS | 30 avril 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,22% | 103 NS | 31 mai 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,22% | 2 049 NS | 31 mai 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,20% | 15 978 NS | 31 mai 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,17% | 12 285 NS | 30 avril 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,13% | 3 281 SH | 8 août 2026 | Quotidien |
| GGUS · Goldman Sachs ETF Trust | 0,11% | 2 357 NS | 31 mai 2026 | N-PORT |
| ILCG · iShares Trust | 0,11% | 13 472 SH | 8 août 2026 | Quotidien |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 216 186 SH | 8 août 2026 | Quotidien |